Literature DB >> 17479933

Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients.

Gianandrea Borgherini1, Patrice Poubeau, Frederik Staikowsky, Manuella Lory, Nathalie Le Moullec, Jean Philippe Becquart, Catherine Wengling, Alain Michault, Fabrice Paganin.   

Abstract

BACKGROUND: Chikungunya is a reemerging disease. In 2005-2006, a severe outbreak occurred on Reunion Island in the southwestern part of the Indian Ocean. Other islands in this area were affected during the same period.
METHODS: Adult patients with acute chikungunya (defined as onset of fever and/or polyarthralgia in the 5 days preceding consultation) and laboratory-confirmed chikungunya who were referred to Groupe Hospitalier Sud Reunion during the period from March 2005 through April 2006 were included in this retrospective study. Their clinical and laboratory features are reported.
RESULTS: Laboratory-confirmed acute chikungunya was documented in 157 patients. The mean age of patients was 57.9 years, and the ratio of male to female patients was 1.24 : 1. Sixty percent of patients had at least 1 comorbidity. Ninety-seven patients (61.8%) were hospitalized, and 60 (38.2%) were treated as outpatients. Five fatalities were reported. One hundred fifty-one patients (96.1%) experienced polyarthralgia, and 129 (89%) experienced fever. Gastrointestinal symptoms were reported by 74 patients (47.1%), and skin rash was reported by 63 (40.1%). Hemorrhagic signs were rare. Lymphopenia and hypocalcemia were the prominent laboratory findings. Severe thrombocytopenia was rarely observed.
CONCLUSIONS: Chikungunya virus can be responsible for explosive outbreaks of disease. Polyarthralgia and fever are the 2 main clinical features. In this era of travel and globalization, chikungunya should be considered in the differential diagnosis of febrile polyarthralgia with an abrupt onset.

Entities:  

Mesh:

Year:  2007        PMID: 17479933     DOI: 10.1086/517537

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  175 in total

1.  Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages.

Authors:  Karine Labadie; Thibaut Larcher; Christophe Joubert; Abdelkrim Mannioui; Benoit Delache; Patricia Brochard; Lydie Guigand; Laurence Dubreil; Pierre Lebon; Bernard Verrier; Xavier de Lamballerie; Andreas Suhrbier; Yan Cherel; Roger Le Grand; Pierre Roques
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

2.  The threat of chikungunya in Oceania.

Authors:  Paul Horwood; Grace Bande; Rosheila Dagina; Laurent Guillaumot; John Aaskov; Boris Pavlin
Journal:  Western Pac Surveill Response J       Date:  2013-06-04

Review 3.  Emerging and re-emerging viruses: A global challenge illustrated by Chikungunya virus outbreaks.

Authors:  Christian A Devaux
Journal:  World J Virol       Date:  2012-02-12

4.  Case reports of neuro-Chikungunya in southern Thailand.

Authors:  Sarunyou Chusri; Pisud Siripaitoon; Siriporn Hirunpat; Khachornsakdi Silpapojakul
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

5.  Performance of the RealStar Chikungunya virus real-time reverse transcription-PCR kit.

Authors:  Marcus Panning; Markus Hess; Waldemar Fischer; Klaus Grywna; Martin Pfeffer; Christian Drosten
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

Review 6.  Novel infectious agents causing uveitis.

Authors:  Moncef Khairallah; Soon Phaik Chee; Sivakumar R Rathinam; Sonia Attia; Venu Nadella
Journal:  Int Ophthalmol       Date:  2009-08-27       Impact factor: 2.031

7.  Chikungunya Virus Disease among Travelers-United States, 2014-2016.

Authors:  Nicole P Lindsey; J Erin Staples; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2018-01-01       Impact factor: 2.345

8.  A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.

Authors:  Juan García-Arriaza; Victoria Cepeda; David Hallengärd; Carlos Óscar S Sorzano; Beate Mareike Kümmerer; Peter Liljeström; Mariano Esteban
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

9.  Chikungunya fever: focus on peripheral markers of pathogenesis.

Authors:  Pierre Roques; Gabriel Gras
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

10.  Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study.

Authors:  Vinod Ravindran; George Alias
Journal:  Clin Rheumatol       Date:  2016-10-04       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.